| Fazle Ali Noor, MD | |
|
1501 Lansdowne Ave Ste 201, Darby, PA 19023-1333 | |
| (610) 534-6230 | |
| (610) 872-5188 |
| Full Name | Fazle Ali Noor |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 25 Years |
| Location | 1501 Lansdowne Ave Ste 201, Darby, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487817672 | NPI | - | NPPES |
| 1023025310002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 25MA08558300 (New Jersey) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | MD433184 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - Waverly Dialysis | Morton, PA | Dialysis facility |
| Fresenius Medical Care Sharon Hill, Llc | Sharon hill, PA | Dialysis facility |
| Mercy Catholic Medical Center- Mercy Fitzgerald | Darby, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Renal Associates Llc | 6901881366 | 29 |
News Archive
Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.
According to the World Health Organization, preeclampsia affects between 2% to 8% of pregnancies. It can cause serious, sometimes fatal, complications in the mother and child.
Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report in the April 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 4 days ago
| Entity Name | Clinical Renal Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689620254 PECOS PAC ID: 6901881366 Enrollment ID: O20040621000636 |
News Archive
Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.
According to the World Health Organization, preeclampsia affects between 2% to 8% of pregnancies. It can cause serious, sometimes fatal, complications in the mother and child.
Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report in the April 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 4 days ago
| Entity Name | Lyons-chvala Nephrology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316044225 PECOS PAC ID: 3779555347 Enrollment ID: O20040812000943 |
News Archive
Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.
According to the World Health Organization, preeclampsia affects between 2% to 8% of pregnancies. It can cause serious, sometimes fatal, complications in the mother and child.
Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report in the April 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fazle Ali Noor, MD 1501 Lansdowne Ave Ste 201, Darby, PA 19023-1333 Ph: (610) 534-6230 | Fazle Ali Noor, MD 1501 Lansdowne Ave Ste 201, Darby, PA 19023-1333 Ph: (610) 534-6230 |
News Archive
Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.
According to the World Health Organization, preeclampsia affects between 2% to 8% of pregnancies. It can cause serious, sometimes fatal, complications in the mother and child.
Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report in the April 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 4 days ago
Dr. William B Mcnamee Jr., M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1503 Lansdowne Ave, Suite 3010, Darby, PA 19023 Phone: 610-237-5817 Fax: 610-237-5802 | |
Dr. Andrew W Mcginnis, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1501 Lansdowne Ave, Suite 104, Darby, PA 19023 Phone: 610-534-6150 | |
Dr. Michael Kevin Mcgarry Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 Lansdowne Ave, Darby, PA 19023 Phone: 610-237-4000 | |
Dhruvan Nimish Patel, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 Lansdowne Ave, Darby, PA 19023 Phone: 610-237-4000 | |
Dr. Kevin Ernest Leahy, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1500 Lansdowne Ave, Darby, PA 19023 Phone: 610-237-4000 | |
Sohiel Deshpande, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1500 Lansdowne Ave, Darby, PA 19023 Phone: 610-237-4000 | |
Celsus Iegbeojai Ebba, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 869 Main St, Darby, PA 19023 Phone: 610-461-2440 Fax: 610-461-2475 |